Skip to content

IEMbase 0261: MANBA-related Beta-mannosidase deficiency

Scope

Field Value
IEMbase ID 261
Nosology 20.3.04.01
Gene MANBA
External IDs OMIM:248510; ORPHA:118
Generated mapping MAPPED; Beta_Mannosidosis.yaml
Candidate DisMech targets Beta_Mannosidosis.yaml
Review date 2026-07-07

IEMbase phenotype signal

IEMbase represents this as MANBA-related beta-mannosidase deficiency, with alternate labels beta-mannosidosis and LBMAN. The record is autosomal recessive and treatability is marked unknown, with no treatment rows in the cached JSON.

Biochemical rows include decreased beta-mannosidase activity in fibroblasts and white blood cells. Clinical rows include angiokeratoma, ataxia, attention disorder, aggressive behavior, behavioral disorder, delayed myelination, dysmorphic features, dysostosis multiplex, foam cells, hyperactivity, hyperreflexia, hypertonia, hypotonia, intellectual disability, polyneuropathy, self mutilation, spasticity, and strabismus.

DisMech phenotype coverage

Beta_Mannosidosis.yaml is the correct local target. The local entry covers autosomal recessive MANBA-related lysosomal beta-mannosidase deficiency, accumulation of mannose-containing oligosaccharides in tissues and body fluids, urinary free oligosaccharides, reduced beta-mannosidase activity, intellectual disability, sensorineural hearing impairment, facial abnormalities, atypical behavior, developmental regression, dysphagia, delayed myelination, recurrent respiratory infections, seizures, angiokeratoma, and supportive care.

Concordance and completeness

Judgement: correct mapping, with IEMbase highlighting phenotype gaps for future review.

IEMbase and DisMech agree on MANBA/beta-mannosidosis identity, autosomal recessive inheritance, decreased beta-mannosidase activity, intellectual disability, behavior/neurodevelopmental involvement, delayed myelination, and angiokeratoma. IEMbase adds more granular neurologic and skeletal prompts: ataxia, hyperreflexia, hypertonia, hypotonia, spasticity, polyneuropathy, dysostosis multiplex, strabismus, self-mutilation, foam cells, and hyperactivity/attention findings.

Curation actions

  • Keep this record mapped to Beta_Mannosidosis.yaml.
  • No mapping correction is needed.
  • Use IEMbase's motor-neurologic, skeletal, ocular, and cellular rows as enrichment prompts during future beta-mannosidosis review.